logo

ITI Pharma and Healthcare Reg Gr

0

0.00(0%)
NAV as of . Log in to view Live prices
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Scheme Information

Logo

ITI Pharma and Healthcare Reg Gr

as of 22 May 2026, 16:37 PM

Scheme Asset Size₹229.56 Cr
Expense Ratio2.35%
Cash Holding1.74704%
Fund TypeOpen-End
PlanDividend
BenchmarkNifty Healthcare TR INR
Launch Date2021-11-11
Exit LoadExit load of 0.50% for investments if redeemed within 3 Months

SIP Calculator

12%
₹5,000
₹500₹10,00,000
10 Years
1 Year40 Years
Invested Amount
Estimated Return

Invested Amount

₹6,00,000

Est. Return

₹5,61,695

Total Value

₹11,61,695

Invested Amount
Estimated Return
Invest Now

Scheme Ratings

-

rated by Value Research

Scheme Riskometer

Your principal will be at Very High Risk

Investment Returns

Absolute Returns

CAGR

In the last 1 months 9.16%
In the last 3 months 11.06%
In the last 6 months 5.04%
In the last 1 Years 5.32%
In the last 3 Years 0.82%
In the last 5 Years 0.00%

Company Holdings

Company Name
Sector
Instrument
Assets
Sun Pharmaceuticals Industries LtdHealthcareE12.40%
Divi's Laboratories LtdHealthcareE8.83%
Apollo Hospitals Enterprise LtdHealthcareE6.25%
Max Healthcare Institute Ltd Ordinary SharesHealthcareE5.22%
Torrent Pharmaceuticals LtdHealthcareE4.82%
Lupin LtdHealthcareE4.44%
Aurobindo Pharma LtdHealthcareE4.36%
Laurus Labs LtdHealthcareE4.24%
Fortis Healthcare LtdHealthcareE3.11%
Cohance Lifesciences LtdHealthcareE3.08%
Neuland Laboratories LtdHealthcareE3.05%
Alkem Laboratories LtdHealthcareE2.93%
Glenmark Pharmaceuticals LtdHealthcareE2.69%
Aster DM Healthcare Ltd Ordinary SharesHealthcareE2.24%
Mankind Pharma LtdHealthcareE1.91%
Sai Life Sciences LtdHealthcareE1.84%
Dr Reddy's Laboratories LtdHealthcareE1.82%
Abbott India LtdHealthcareE1.79%
Park Medi World LtdHealthcareE1.67%
Cipla LtdHealthcareE1.64%
Ipca Laboratories LtdHealthcareE1.50%
Linde India LtdBasic MaterialsE1.37%
Sun Pharmaceutical Industries Limited-DG1.36%
Shaily Engineering Plastics LtdBasic MaterialsE1.29%
Jubilant Ingrevia Ltd Ordinary SharesBasic MaterialsE1.28%
SBI Life Insurance Co LtdFinancial ServicesE1.26%
FDC LtdHealthcareE1.21%
Piramal Pharma LtdHealthcareE1.20%
Biocon LtdHealthcareE1.19%
HealthCare Global Enterprises LtdHealthcareE1.09%
Rainbow Childrens Medicare LtdHealthcareE0.99%
GlaxoSmithKline Pharmaceuticals LtdHealthcareE0.94%
Standard Engineering Technology LtdIndustrialsE0.91%
Shilpa Medicare LtdHealthcareE0.88%
Poly Medicure LtdHealthcareE0.79%
Caplin Point Laboratories LtdHealthcareE0.78%
Supriya Lifescience LtdHealthcareE0.77%
Zydus Lifesciences LtdHealthcareE0.65%
Syngene International LtdHealthcareE0.45%
Net Receivables / (Payables)-C3.10%
Cash Offset For Derivatives-CQ1.36%
Sumitomo Chemical India Ltd Ordinary Shares-E-
OneSource Specialty Pharma Ltd-E-
Orchid Pharma Ltd-E-
AstraZeneca Pharma India Ltd-E-

Sector Holding Analysis

Equity / Debt / Cash Split

Loading chart…

Equity

98.25%

Cash

1.75%

Equity sector allocation

Loading chart…

Basic Materials

3.94%

Financial Services

1.26%

Healthcare

90.79%

Industrials

0.91%

Others

3.1%

Fund House Contact Details

Websitewww.itimf.com
Phone022-66214999
Logo
ITI Asset Management Limited

Asset Management Company

About ITI Pharma and Healthcare Reg Gr

Investment Objective of the Scheme

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Key Features of The Fund

5-year return

-

Fund Manager

Dhimant Shah

Risk Profile

Very High Risk

Expense Ratio

2.35%

Fund Size

₹229.56 Cr

FAQ's

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy